-
Mashup Score: 42Testicular cancer is highly treatable - Mayo Clinic Comprehensive Cancer Center Blog - 5 month(s) ago
Dr. Bradley Leibovich discusses testicular cancer symptoms and explains that a cure is possible for most people diagnosed with the […]
Source: cancerblog.mayoclinic.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 7Cancer of the Testis - Cancer Stat Facts - 5 month(s) ago
Testicular Cancer statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
#TesticularCancer is most frequently diagnosed among younger males, especially among those aged 20-34. Visit our Cancer Stat Facts sheet to learn more: https://t.co/45AUqAvpbI https://t.co/QjNDEFcITC
-
-
Mashup Score: 24Detecting Early Testicular Cancer Relapse with Plasma MicroRNA Analysis - Lucia Nappi - 5 month(s) ago
Zach Klaassen interviews Lucia Nappi about her research on the role of microRNAs in early-stage testicular cancer. MicroRNAs are small RNA fragments crucial for the regulation of oncogenes and tumor suppressors, with certain microRNAs notably overexpressed in testicular cancer. Dr. Nappi’s team analyzed the microRNA-371 in plasma samples from stage I testicular cancer patients, finding that…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Detecting early #TesticularCancer relapse with plasma microRNA analysis. @LuciaNappi4 @VanProstateCtr joins @zklaassen_md @GACancerCenter to discuss her research and implications for the results on UroToday > https://t.co/4m7Rpam1nF https://t.co/2ugsKL61vk
-
-
Mashup Score: 6Cancer of the Testis - Cancer Stat Facts - 6 month(s) ago
Testicular Cancer statistics
Source: seer.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
#TesticularCancer is most frequently diagnosed among younger males, especially among those aged 20-34. Visit our Cancer Stat Facts sheet to learn more: https://t.co/45AUqAvpbI https://t.co/QjNDEFcITC
-
-
Mashup Score: 22Hospital Anxiety and Depression Scale (HADS) Score Trends Among Testicular Cancer Survivors: a Longitudinal Study - Khalid Alkhatib - 6 month(s) ago
Zach Klaassen hosts Khalid Alkhatib to discuss the mental health of testicular cancer patients. Dr. Alkhatib shares findings from his study, explaining that the disease impacts a younger demographic, making these patients more susceptible to anxiety and depression. The research revealed that the patients’ anxiety and depression levels did not improve over time after active treatment, contrary to…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Hospital anxiety and depression scale (HADS) score trends among #TesticularCancer survivors: a longitudinal study. @Khalid_Alkhatib @PennUrology joins @zklaassen_md @GACancerCenter in this discussion on the mental health of testicular cancer patients > https://t.co/fzd0j5x1ki https://t.co/J4LQBwFaov
-
-
Mashup Score: 0Identifying New Prognostic Factors for Relapse in Patients With Stage I Testicular Seminoma - 6 month(s) ago
Thomas Wagner, MD, of the Department of Oncology, Copenhagen University Hospital, Rigshospitalet, details his study published in the Journal of Clinical Oncology on finding and assessing novel prognostic factors for relapse in patients with clinical stage I testicular seminoma. Dr. Wagner highlights the risk of relapse for these patients, whether the known risk factors for relapse are adequate or in need of improvement, and the inspiration for his study. Then, he explains the relapse rate found among his
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet-
What are the problems with current risk stratification for relapse in stage 1 #testicularcancer? Dr. Thomas Wagner of Copenhagen University Hospital details the shortcomings as well as novel prognostic factors for relapse...https://t.co/AFd9PdPD8m https://t.co/wKgtCo7esN
-
-
Mashup Score: 24Detecting Early Testicular Cancer Relapse with Plasma MicroRNA Analysis - Lucia Nappi - 6 month(s) ago
Zach Klaassen interviews Lucia Nappi about her research on the role of microRNAs in early-stage testicular cancer. MicroRNAs are small RNA fragments crucial for the regulation of oncogenes and tumor suppressors, with certain microRNAs notably overexpressed in testicular cancer. Dr. Nappi’s team analyzed the microRNA-371 in plasma samples from stage I testicular cancer patients, finding that…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Detecting early #TesticularCancer relapse with plasma microRNA analysis. @LuciaNappi4 @VanProstateCtr joins @zklaassen_md @GACancerCenter to discuss her research and implications for the results on UroToday > https://t.co/4m7Rpam1nF https://t.co/2ugsKL61vk
-
-
Mashup Score: 0Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer - 7 month(s) ago
What is the role of pcRPLND in men with retroperitoneal vital cancer after first-line chemotherapy? This question arises because of the potential predictive value of miR371 in identifying residual cancer even before pcRPLND! @cdfankhauser shared data within a multicenter cohort study redefining future practice in the miR371 era.
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🤔 What is the role of pcRPLND in men w/ retroperitoneal #TesticularCancer following 1st line chemotherapy?// Does miR37 identify residual cancer before pcRPLND? // @cdfankhauser shares data w/in a multicenter cohort study redefining future practice https://t.co/ngG49M7TE7 #tscsm https://t.co/LRJGBeYPLr
-
-
Mashup Score: 0Hospital Anxiety and Depression Scale (HADS) Score Trends Among Testicular Cancer Survivors: a Longitudinal Study - Khalid Alkhatib - 7 month(s) ago
Zach Klaassen hosts Khalid Alkhatib to discuss the mental health of testicular cancer patients. Dr. Alkhatib shares findings from his study, explaining that the disease impacts a younger demographic, making these patients more susceptible to anxiety and depression. The research revealed that the patients’ anxiety and depression levels did not improve over time after active treatment, contrary to…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Hospital anxiety and depression scale (HADS) score trends among #TesticularCancer survivors: a longitudinal study. @Khalid_Alkhatib @PennUrology joins @zklaassen_md @GACancerCenter in this discussion on the mental health of testicular cancer patients > https://t.co/fzd0j5x1ki https://t.co/U9iPcokVrg
-
-
Mashup Score: 1
Aditya Bagrodia, MD, FACS, of UC San Diego Health, and David Ambinder, MD, a urology resident at New York Medical College/Westchest er Medical Center, walk through a community urologist’s initial approach to a patient who presents with a testicular mass, as well as considerations for orchiectomy and eventual cure. Dr. Bagrodia begins by explaining how this is a common clinical scenario and what should be discussed with the patient, what serum tumor markers and other items should be addressed for a
Source: guoncologynow.comCategories: Latest Headlines, Partners & KOLsTweet-
Do you agree with @AdityaBagrodia's preferred processes after a testicular mass is excised? Hear more from him and @SimplyUroMD on #testicularcancer management from initial presentation to orchiectomy and cure https://t.co/ehRc5JRdzj https://t.co/LfmKGlA2om
-
#TesticularCancer is not common, and it's usually highly treatable. Here's what you need to know about this disease, according to @MayoCancerCare urologic oncologist Dr. Bradley Leibovich: https://t.co/lyF0feexwJ